LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $10.2M invested in LAVA Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
3
Reduced
3
Closed
8
Calls
$68K
Puts
–
Net Calls
+$68K
Net Calls Change
+$68K
Top Buyers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$2.49M |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$30.9K |
| 3 |
LDNAM
Lepercq De Neuflize Asset Management
New York
|
+$29.2K |
| 4 |
Two Sigma Investments
New York
|
+$11.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.38K |
Top Sellers
| 1 |
BC
Bruce & Co
Chicago,
Illinois
|
-$318K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$98.9K |
| 3 |
EGM
Engineers Gate Manager
New York
|
-$30.4K |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$20.5K |
| 5 |
VF
Virtu Financial
New York
|
-$19K |
